Summary
The Paris Prospective Study is a long-term investigation of the incidence of coronary heart disease in a large population of working men. The first follow-up examination involved 7,038 men, aged 43–54 years. Subjects with impaired glucose tolerance or diabetes (n=943) were selected from the total population for a separate analysis of coronary heart disease mortality risk factors. During a mean follow-up of 11 years, 26 of these 943 subjects with abnormal glucose tolerance died from coronary heart disease. Univariate analysis showed that plasma triglyceride level (p<0.006), plasma cholesterol level (p<0.02), and plasma insulin level both fasting and 2-h post-glucose load (p<0.02), were significantly higher in subjects who died from coronary heart disease compared to those who did not. In multivariate regression analysis using the Cox model, plasma triglyceride level was the only factor positively and significantly associated with coronary death. The distribution of plasma triglyceride levels was clearly higher for the subjects who died from coronary heart disease compared to those who did not die from this cause or were alive at the end of the follow-up. This new epidemiological evidence that hypertriglyceridaemia is an important predictor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes suggests a possible role of dyslipidaemia in the excessive occurrence of atherosclerotic vascular disease in this category of subjects.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Garcia MJ, McNamara PM, Gordon T, Kannel WB (1974) Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 23: 105–111
WHO Expert Committee on Diabetes Mellitus (1980) Second report. Technical report series 646. WHO, Geneva
Vigorita VJ, Moore GW, Hutchins GM (1980) Absence of correlation between coronary arterial atherosclerosis and severity or duration of diabetes mellitus of adult onset. Am J Cardiol 46: 535–542
Jarrett RJ, Shipley MJ (1988) Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease — putative association via common antecedents; further evidence from the Whitehall Study. Diabetologia 31: 737–740
Pyörälä K (1979) Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2: 131–141
Welborn TA, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 2: 154–160
Ducimetiére P, Eschwége E, Papoz L, Richard JL, Claude JR, Rosselin GE (1980) Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in a middle-aged population. Diabetologia 19: 205–210
Eschwége E, Richard JL, Thibult N, et al. (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study ten years later. Horm Metabol Res Suppl Series 15: 41–56
Ganda OMP (1985) Pathogenesis of macrovascular disease including the influence of lipids. In: Marble A, Krall LP, Bradley AR, Christlieb AR, Soeldner JS (eds) Joslin's diabetes mellitus. Lea & Febiger, Philadelphia, pp 217–250
Barrett-Connor E, Grundy SM, Holdbrook MJ (1982) Plasma lipids and diabetes mellitus in an adult community. Am J Epidemiol 115: 657–663
Saudek CD, Eder HA (1979) Lipid metabolism in diabetes mellitus. Am J Med 66: 843–852
Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL (1983) Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol 118: 326–337
Zavaroni I, Dall'Aglio E, Alpi O et al. (1985) Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 55: 259–266
Cambien F, Warnet M, Eschwége E, Richard JL, Rosselin G (1987) Body mass, blood pressure, glucose and lipids. Does plasma insulin explain their relationships? Arateriosclerosis 7: 197–202
Cahill GF Jr (1988) Beta-cell deficiency, insulin resistance, or both? N Engl J Med 318: 1268–1270
Ducimetière P, Richard JL, Claude JR (1981) Les cardiopathies ischémiques: incidence et facteurs de risque. L'Etude Prospective Parisienne. Editions INSERM, Paris, pp 9–21
Rosselin G, Assan R, Yalow RS, Berson SA (1966) Separation of antibody bound and unbound peptide hormone labelled with iodine 131 by talcum powder and precipitates silica. Nature 212: 355–357
Anonymous (1963) Methodologie Technicon Auto Analyser ‘N’ 2a, 2nd edn Dec. Technicon Ltd
Etienne G, Papin JP, Renault M (1963) Une méthode simple du dosage du cholestérol par voie automatique. Ann Biol Clin 21: 851–853
Claude JR, Corre F (1968) Considérations pratiques sur le dosage semi-automatique des triglycérides sériques par fluorométrie (méthode de Kiessler et Lederer). Comparaison avec la méthode manuelle colorimétrique de Van Handel et Zilversmit. Ann Biol Clin 26: 451–454
Cox DR (1972) Regression models and life tables (with discussion). J R Statist Soc B34: 187–220
Stamler J, Stamler R (1979) Asymptomatic hyperglycaemia and coronary heart disease. A series of papers by the International Collaborative Group based on studies in fifteen populations. Joint discussion. J Chron Dis 32: 829–837
Stern MP, Rosenthal M, Haffner SM (1985) A new concept of impaired glucose tolerance: relation to cardiovascular risk. Arteriosclerosis 5: 311–314
Editorial (1980) Diabetes, hyperglycaemia and coronary heart disease. Lancet I: 346
Janka HU (1985) Five-year incidence of major macrovascular complications in diabetes mellitus. Horm Metabol Res Suppl Series 15: 15–19
West KM, Ahuja MMS, Bennett PH, et al. (1983) The role of circulating glucose and triglyceride concentrations and their interaction with other risk factors as determinants of arterial disease in nine diabetic population samples from the WHO Multinational Study. Diabetes Care 6: 361–369
Hulley SB, Rosenman RH, Bawol RD, Brand RJ (1980) Epidemiology as a guide to clinical decisions. The association between triglyceride and coronary heart disease. N Engl J Med 302: 1383–1418
Castelli WP (1986) The triglyceride issue: a view from Framingham. Am Heart J 112: 432–437
Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetière P, Claude JR (1986) Is the level of serum triglyceride a significant predictor of coronary death in “normocholesterolemic” subjects? The Paris Prospective Study. Am J Epidemiol 124: 624–632
Nikkilä EA (1978) Metabolic and endocrine control of plasma high density lipoprotein concentration. Relation to catabolism of triglyceride-rich lipoproteins. In: Gotto AM, Miller NE, Oliver MF (eds) High density lipoproteins and atherosclerosis. Elsevier, Amsterdam, pp 177–192
Albrink MJ, Krauss RM, Lindgren FT (1980) Intercorrelations among plasma high density lipoprotein, obesity and triglycerides in a normal population. Lipids 15: 668–676
Gordon T, Castelli WP, Hjortland MC, et al. (1977) High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62: 707–714
Abrams JJ, Ginsberg H, Grundy SM (1982) Metabolism of cholesterol and plasma triglycerides in non-ketotic diabetes mellitus. Diabetes 31: 903–910
Uusitupa M, Siitonen O, Voutilainen E, et al. (1986) Serum lipids and lipoproteins in newly-diagnosed non-insulin-dependent (Type II) diabetic patients with special reference to factors influencing HDL-cholesterol and triglyceride levels. Diabetes Care 9: 17–22
Steiner G (1986) Hypertriglyceridemia and carbohydrate intolerance: interrelations and therapeutic implications. Am J Cardiol 57: 27G-30G
Fossati P, Romon-Rousseaux M (1987) Insulin and HDL cholesterol metabolism. Diabete Metabolisme (Paris) 13: 390–394
Bernstein RM, Davis BM, Olefsky JM, Reaven GM (1978) Hepatic insulin responsiveness in patients with endogenous hypertriglyceridaemia. Diabetologia 14: 249–253
Stalder M, Pometta D, Suenram A (1981) Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men. Diabetologia 21: 544–548
Laakso M, Pyörälä K, Voutilainen E, Marniemi J (1987) Plasma insulin, serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects. Am J Epidemiol 125: 611–621
Reaven GM, Chen YDI (1988) Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metabol Rev 4: 639–652
Bates SR, Murphy PL, Feng Z, Kanazawa T, Getz GS (1984) Very low density lipoproteins promote triglyceride accumulation in macrophages. Arteriosclerosis 4: 103–114
Steiner G, Vranic M (1982) Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential. Intern J Obesity 6 [Suppl 1]: 117–124
Reaven GM, Greenfeld MS (1981) Diabetes hypertriglyceridemia. Evidence for three clinical syndromes. Diabetes 30 [Suppl 2]: 66–75
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Colwell JA, Winocour PD, Lopes-Virella M, Halushka PV (1983) New concepts about the pathogenesis of atherosclerosis in diabetes mellitus. Am J Med 75: 67–80
Schwandt P (1985) Very low density lipoproteins in Type II diabetes mellitus and risk of atherosclerosis. Horm Metabol Res Suppl Series 15: 83–87
Pyörälä K, Uusitupa M, Laakso M, Siitonen O, Niskanen L, Rönnemaa T (1987) Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus. Diabete Metabolisme (Paris) 13: 345–349
Thomas BJ, Jarrett JR, Keen H, Ruskin JH (1982) Relation of habitual diet to fasting plasma insulin concentration and the insulin response to oral glucose. Hum Nutr Clin Nutr 36c: 49–56
Pedersen O, Beck-Nielsen H, Heding L (1980) Increased insulin receptors after exercise in patients with insulin dependent diabetes mellitus. N Engl J Med 302: 886–892
Gordon DJ, Witztum JL, Hunninghake D (1983) Habitual physical activity and high density lipoprotein in men with primary hypercholesterolemia. The Lipid Research Clinic Coronary Primary Prevention Trial. Circulation 67: 512–520
Garg A, Grundy SM (1988) Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. N Engl J Med 318: 81–86
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fontbonne, A., Eschwège, E., Cambien, F. et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Diabetologia 32, 300–304 (1989). https://doi.org/10.1007/BF00265546
Received:
Revised:
Issue date:
DOI: https://doi.org/10.1007/BF00265546